semaglutide binge eating disorder Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? Semaglutide vs Tirzepatide: Which is

Primary Uses and FDA Approvals Ozempic Primary FDA approval: Type 2 diabetes management Secondary benefit: Weight loss Typical weekly doses: 0.25 mg to 2 mg Wegovy Primary FDA approval: Chronic weight management Specifically approved for: Adults with BMI 30, or Adults with BMI 27 with at least one weight-related condition Typical weekly doses: 0.25 mg to 2.4 mg Key Differences (Wegovy vs Ozempic) Dosing Protocol Wegovy follows a more gradual dose escalation pattern and reaches a higher maximum dose than Ozempic

Learn more about how IV therapy works on our IV Vitamin Therapy Overview page

The platform connects patients with partner compounding pharmacies for preparation of compounded semaglutide and tirzepatide

Excitatory amino acid transporters (EAATs): Glutamate transport and beyond